Rebecca Penn

4.3k total citations · 2 hit papers
10 papers, 1.5k citations indexed

About

Rebecca Penn is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rebecca Penn has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Rebecca Penn's work include SARS-CoV-2 and COVID-19 Research (5 papers), Influenza Virus Research Studies (4 papers) and interferon and immune responses (3 papers). Rebecca Penn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Influenza Virus Research Studies (4 papers) and interferon and immune responses (3 papers). Rebecca Penn collaborates with scholars based in United Kingdom, Italy and Spain. Rebecca Penn's co-authors include William Barclay, Laury Baillon, Olivia C. Swann, Jie Zhou, Jonathan C. Brown, Michael Osborn, Brian Hanley, Daniel H. Goldhill, Mauro Giacca and Luca Braga and has published in prestigious journals such as Nature, Nature Communications and Clinical Infectious Diseases.

In The Last Decade

Rebecca Penn

10 papers receiving 1.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets

2021 464 citations Thomas P. Peacock, Daniel H. Goldhill et al. Nature Microbiology profile →
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

2021 281 citations Luca Braga, Hashim Ali et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebecca Penn United Kingdom	9	1.1k	430	254	197	171	10	1.5k
Emma S. Winkler United States	15	1.2k 1.1×	350 0.8×	203 0.8×	320 1.6×	223 1.3×	20	1.7k
Paul W. Rothlauf United States	9	1.7k 1.5×	535 1.2×	172 0.7×	206 1.0×	150 0.9×	12	2.0k
Adeline Heurich Germany	6	1.4k 1.3×	276 0.6×	302 1.2×	244 1.2×	215 1.3×	6	1.8k
Stefanie Gierer Germany	7	1.5k 1.4×	280 0.7×	312 1.2×	250 1.3×	214 1.3×	8	1.9k
Heike Hofmann-Winkler Germany	17	2.0k 1.8×	446 1.0×	291 1.1×	293 1.5×	263 1.5×	23	2.4k
Coralie Valle France	6	1.0k 0.9×	229 0.5×	180 0.7×	137 0.7×	113 0.7×	9	1.3k
Kenneth H. Dinnon United States	14	1.6k 1.4×	271 0.6×	295 1.2×	246 1.2×	248 1.5×	25	1.9k
Vanessa Monteil Sweden	14	1.6k 1.4×	515 1.2×	442 1.7×	182 0.9×	136 0.8×	23	2.1k
Changfa Fan China	14	1.1k 1.0×	327 0.8×	88 0.3×	169 0.9×	212 1.2×	32	1.5k
Thomas Kuri Germany	10	841 0.7×	212 0.5×	164 0.6×	247 1.3×	140 0.8×	11	1.2k

Countries citing papers authored by Rebecca Penn

Since Specialization

Citations

This map shows the geographic impact of Rebecca Penn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Penn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Penn more than expected).

Fields of papers citing papers by Rebecca Penn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Penn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Penn. The network helps show where Rebecca Penn may publish in the future.

Co-authorship network of co-authors of Rebecca Penn

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Penn. A scholar is included among the top collaborators of Rebecca Penn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Penn. Rebecca Penn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Sheppard, Carol, Daniel H. Goldhill, Olivia C. Swann, et al.. (2023). An Influenza A virus can evolve to use human ANP32E through altering polymerase dimerization. Nature Communications. 14(1). 6135–6135. 14 indexed citations

Penn, Rebecca, John S. Tregoning, Katie E. Flight, et al.. (2022). Levels of Influenza A Virus Defective Viral Genomes Determine Pathogenesis in the BALB/c Mouse Model. Journal of Virology. 96(21). e0117822–e0117822. 10 indexed citations

Penn, Rebecca, et al.. (2022). Naïve Human Macrophages Are Refractory to SARS-CoV-2 Infection and Exhibit a Modest Inflammatory Response Early in Infection. Viruses. 14(2). 441–441. 9 indexed citations

Braga, Luca, Hashim Ali, Ilaria Secco, et al.. (2021). Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature. 594(7861). 88–93. 281 indexed citations breakdown →

Peacock, Thomas P., Daniel H. Goldhill, Jie Zhou, et al.. (2021). The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nature Microbiology. 6(7). 899–909. 464 indexed citations breakdown →

Godlee, Alexandra, Daniel Geh, Nick D. Jones, et al.. (2021). Latent Cytomegalovirus Infection and Previous Capsular Polysaccharide Vaccination Predict Poor Vaccine Responses in Older Adults, Independent of Chronic Kidney Disease. Clinical Infectious Diseases. 73(4). e880–e889. 9 indexed citations

McKay, Paul F., Kai Hu, Anna K. Blakney, et al.. (2020). Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Nature Communications. 11(1). 3523–3523. 339 indexed citations

Hanley, Brian, Kikkeri N. Naresh, Candice Roufosse, et al.. (2020). Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. The Lancet Microbe. 1(6). e245–e253. 385 indexed citations

Penn, Rebecca, et al.. (2019). Aberrant RNA replication products of highly pathogenic avian influenza viruses and its impact in the mammalian associated cytokine storm. Access Microbiology. 1(1A). 2 indexed citations

10.

Engelhardt, Othmar G., Chantal Edge, Kate Guilfoyle, et al.. (2018). Comparison of single radial immunodiffusion, SDS-PAGE and HPLC potency assays for inactivated influenza vaccines shows differences in ability to predict immunogenicity of haemagglutinin antigen. Vaccine. 36(29). 4339–4345. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact